Research and Markets: Authoritative Insight into AstraZeneca at a Strategic and Local...

Research and Markets: Authoritative Insight into AstraZeneca at a Strategic and Local Level

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/reports/c92277) has announced the
addition of "AstraZeneca IMS Company Profile" to their offering.

Each individual IMS Company Profile analyzes the critical
components that make up a pharmaceutical company, providing you with a
clear assessment of the relative strengths and weaknesses of a
company's business strategy.

-- Critical analyses provided by an in-house expert team

-- 90+ full in-depth company profiles covering all major
pharmaceutical companies worldwide including private companies

-- Includes some Generic, Biotechnology and Drug Delivery
companies

-- Includes IMS Health sales data on products and therapies

-- In depth product and R&D reviews, including clinical trial,
lifecycle management, competition and analysts forecasts

-- Mergers and acquisitions; licensing agreements

-- Forecasts and comments from leading financial analysts

-- Companies' conferences, annual reports, press releases

-- Comments from stockbrokers/analysts reports used throughout
the profile and especially within the Strategy, Financial and
Product sections.

Key Discussions:

Corporate Structure

Strategy statement

Highlights a company's strengths/weaknesses and its potential for
future growth. The strategy analysis gives you an insight into the
following:

-- M&A

-- Regional strategies

-- Therapeutic focus

-- R&D strategy

-- Licensing activities

-- Commentary on future prospects, including brokers' overviews

-- Interview with a key person (where available), including
quotes and opinions

-- Forecasting table (top 30 companies only), showing events with
major potential impact

Financial Review

Company sales performance as well as analyst's comments and
forecasts.

Company Sales Performance:

-- Financial review

-- Latest results

-- Sales by geographical region & leading country

-- Sales by country and subsidiary

-- Analysis comments

Product Portfolio

Company Profiles reviews up to 40 products per company, whilst
annual reports from the top 10 pharmaceutical companies cover up to a
maximum of 10 drugs.

The section shows:

-- Summary table of products facing patent expiry.

-- Breakdown by relevant therapy area, within which, each product
is discussed under the following headings: general, licensing,
patents, clinical data, lifecycle management, competition and
analysts' forecasts/comments.

R&D Pipelines

Comprehensive details of the projects that the company has in its
R&D pipeline including:

-- Research pipeline summary table.

-- Introduction to the R&D activities of the company.

-- Breakdown by relevant therapy area, within which, each project
is detailed (up to 2 A4 pages), including information on
clinical status and analysts' forecasts.

-- Quotes from senior personnel gleaned from conferences may also
be included in this section when available.

Key figures

-- Sales by business segment.

-- Sales by geographical region.

Analyst figures

IMS sales data

-- Pharmaceutical sales by geographical region and leading
countries.

-- Top 5 third level therapeutic classes.

-- Leading international products

-- Pharmaceutical sales analysis by age

Employee data

Licensing/Co-Marketing Agreements

Displayed in a tabular format to enable you to have "at a glance"
review of the licensing activities of the company.

Three sections are available to review licensing activities:

-- Marketed products

-- R&D pipeline products

-- General research collaborations, including combinatorial
chemistry, proprietary technologies etc.

Major Events

Summary of the major events that have affected the company. This
includes recent and historical events.

Two sections

-- Mergers and Acquisitions

-- Other major events

Events are organised in chronological order.

Subsidiaries listing

Mini-profile of each subsidiary that the company has worldwide
showing address, major contacts and principal products.

Source: IMS Health

For more information visit
http://www.researchandmarkets.com/reports/c92277

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
Fax: +353 1 4100 980

Copyright Business Wire 2008